BIO-TECHNE Corp vs Vistra Corp — how do they compare? BIO-TECHNE Corp trades at $71.63 (market cap $11.16B), while Vistra Corp trades at $162.5 (market cap $53.27B). The key difference: Vistra Corp is far larger — about 4.8× BIO-TECHNE Corp's market cap, and Vistra Corp pays the higher dividend (0.58%). Which is the better fit depends on your goals.
| TECH | VST | |
|---|---|---|
Market Cap | $11.16B | $53.27B |
Sector | Health | Technology |
52-Week High | $72.12 | $217.92 |
52-Week Low | $43.31 | $134.71 |
Enterprise Value | $11.24B | $75.03B |
Dividend Yield | 0.45% | 0.58% |
Trailing returns across standard periods
Latest headlines on both assets
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →Vistra is a leading integrated retail electricity and power generation company that serves as a critical infrastructure provider for the digital economy. It operates a diversified portfolio of zero-carbon nuclear and renewable assets alongside a massive, flexible natural gas fleet, positioning it as an indispensable partner for energy-intensive AI data centers and industrial electrification.
Read more on VST →